PHILADELPHIA--(BUSINESS WIRE)--Revitas announced today that Impax Laboratories, Inc. (NASDAQ: IPXL), a technology-based specialty pharmaceutical company, will move forward with adoption of Revitas’s strategic Flex™ technology platform and expand its use of Revitas’s Enterprise Revenue Dynamics (ERD) solutions across the enterprise.
